Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 201
Filtrar
1.
Cell Tissue Res ; 385(3): 785-801, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33885964

RESUMO

The sperm-derived oocyte activating factor, phospholipase C zeta (PLC ζ), is the only PLC isoform reported in cattle. The objectives were to (1) localize PLC ζ in fresh and capacitated bovine sperm and (2) investigate the activation of PLC ζ during bull sperm capacitation and contributions of PLC activity to this process. We confirmed interaction of testis-specific isoform of Na/K-ATPase (ATP1A4) with PLC ζ (immunolocalization and immunoprecipitation) and tyrosine phosphorylation (immunoprecipitation) of PLC ζ (a post-translational protein modification commonly involved in activation of PLC in somatic cells) during capacitation. Furthermore, incubation of sperm under capacitating conditions upregulated PLC-mediated hyperactivated motility, tyrosine phosphoprotein content, acrosome reaction, and F-actin formation (flow cytometry), implying that PLC activity is enhanced during capacitation and contributing to these capacitation processes. In conclusion, we inferred that PLC ζ is activated during capacitation by tyrosine phosphorylation through a mechanism involving ATP1A4, contributing to capacitation-associated biochemical events.


Assuntos
Ouabaína/uso terapêutico , Capacitação Espermática/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos , Animais , Bovinos , Masculino , Ouabaína/farmacologia
2.
Eur J Pharmacol ; 886: 173536, 2020 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-32896550

RESUMO

The cardiac plexus, which contains parasympathetic ganglia, plays an important role in regulating cardiac function. Histamine is known to excite intracardiac ganglion neurons, but the underlying mechanism is obscure. In the present study, therefore, the effect of histamine on rat intracardiac ganglion neurons was investigated using perforated patch-clamp recordings. Histamine depolarized acutely isolated neurons with a half-maximal effective concentration of 4.5 µM. This depolarization was markedly inhibited by the H1 receptor antagonist triprolidine and mimicked by the H1 receptor agonist 2-pyridylethylamine, thus implicating histamine H1 receptors. Consistently, reverse transcription-PCR (RT-PCR) and Western blot analyses confirmed H1 receptor expression in the intracardiac ganglia. Under voltage-clamp conditions, histamine evoked an inward current that was potentiated by extracellular Ca2+ removal and attenuated by extracellular Na+ replacement with N-methyl-D-glucamine. This implicated the involvement of non-selective cation channels, which given the link between H1 receptors and Gq/11-protein-phospholipase C signalling, were suspected to be transient receptor potential canonical (TRPC) channels. This was confirmed by the marked inhibition of the inward current through the pharmacological disruption of either Gq/11 signalling or intracellular Ca2+ release and by the application of the TRPC blockers Pyr3, Gd3+ and ML204. Consistently, RT-PCR analysis revealed the expression of several TRPC subtypes in the intracardiac ganglia. Whilst histamine was also separately found to inhibit the M-current, the histamine-induced depolarization was only significantly inhibited by the TRPC blockers Gd3+ and ML204, and not by the M-current blocker XE991. These results suggest that TRPC channels serve as the predominant mediator of neuronal excitation by histamine.


Assuntos
Gânglios/citologia , Gânglios/efeitos dos fármacos , Coração/efeitos dos fármacos , Coração/inervação , Histamina/farmacologia , Canais Iônicos/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Canais de Cátion TRPC/efeitos dos fármacos , Animais , Sinalização do Cálcio/efeitos dos fármacos , Feminino , Agonistas dos Receptores Histamínicos/farmacologia , Antagonistas dos Receptores Histamínicos H1/farmacologia , Masculino , Meglumina/farmacologia , Técnicas de Patch-Clamp , Canais de Potássio/efeitos dos fármacos , Piridinas/farmacologia , Ratos , Ratos Wistar , Triprolidina/farmacologia , Fosfolipases Tipo C/efeitos dos fármacos
3.
Reprod Domest Anim ; 54(9): 1236-1243, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31319005

RESUMO

Granulosa cells play important roles in the regulation of ovarian functions. Phospholipase C is crucial in several signalling pathways and could participate in the molecular mechanisms of cell proliferation, differentiation and ageing. The objective of this study was to identify the effects of phospholipase C on the steroidogenesis of oestradiol and progesterone in porcine granulosa cells cultured in vitro. Inhibitor U73122 or activator m-3M3FBS of phospholipase C was added to the in vitro medium of porcine granulosa cells, respectively. The secretion of oestradiol decreased after 2 hr, 8 hr, 12 hr, 24 hr and 48 hr of treatment with 500 nM U73122 (p < .05) and decreased after 2 hr of treatment in the 500 nM m-3M3FBS addition group (p < .05). The secretion of progesterone increased after 4 hr of treatment with 500 nM U73122 (p < .05) and increased after 2 hr and 8 hr of treatment in the 500 nM m-3M3FBS addition group (p < .05). The ratio of oestradiol to progesterone decreased at each time point, except 8 hr after the addition of 500 nM U73122 (p < .05). The ratio of oestradiol to progesterone decreased after 2 hr (p < .05) of treatment with 500 nM m-3M3FBS. In genes that regulate the synthesis of oestradiol or progesterone, the mRNA expression of CYP11A1 was markedly increased (p < .05), and the mRNA expression of other genes did not change significantly in the U73122 treatment group, while the addition of m-3M3FBS did not change those genes significantly despite the contrary trend. Our results demonstrated that phospholipase C can be a potential target to stimulate the secretion of oestradiol and suppress progesterone secretion in porcine granulosa cells cultured in vitro, which shed light on a novel biological function of phospholipase C in porcine granulosa cells.


Assuntos
Estradiol/metabolismo , Células da Granulosa/efeitos dos fármacos , Progesterona/metabolismo , Fosfolipases Tipo C/efeitos dos fármacos , Animais , Células Cultivadas , Enzima de Clivagem da Cadeia Lateral do Colesterol/genética , Enzima de Clivagem da Cadeia Lateral do Colesterol/metabolismo , Estrenos/farmacologia , Feminino , Expressão Gênica , Células da Granulosa/enzimologia , Células da Granulosa/metabolismo , Inibidores de Fosfodiesterase , Pirrolidinonas/farmacologia , Sulfonamidas/farmacologia , Sus scrofa
4.
Arch Oral Biol ; 89: 49-54, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29471192

RESUMO

OBJECTIVE: Magnolol, a polyphenol compound from herbal medicines, was shown to alter physiology in various cell models. However, the effect of magnolol on Ca2+ homeostasis and its related physiology in oral cancer cells is unclear. This study examined whether magnolol altered Ca2+ signaling and cell viability in OC2 human oral cancer cells. METHODS: Cytosolic Ca2+ concentrations ([Ca2+]i) in suspended cells were measured by using the fluorescent Ca2+-sensitive dye fura-2. Cell viability was examined by 4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate] water soluble tetrazolium-1 (WST-1) assay. RESULTS: Magnolol at concentrations of 20-100 µM induced [Ca2+]i rises. Ca2+ removal reduced the signal by approximately 50%. Magnolol (100 µM) induced Mn2+ influx suggesting of Ca2+ entry. Magnolol-induced Ca2+ entry was partially suppressed by protein kinase C (PKC) regulators, and inhibitors of store-operated Ca2+ channels. In Ca2+-free medium, treatment with the endoplasmic reticulum Ca2+ pump inhibitor 2,5-di-tert-butylhydroquinone (BHQ) abolished magnolol-evoked [Ca2+]i rises. Conversely, treatment with magnolol abolished BHQ-evoked [Ca2+]i rises. Inhibition of phospholipase C (PLC) with U73122 partially inhibited magnolol-induced [Ca2+]i rises. Magnolol at 20-100 µM decreased cell viability, which was not reversed by pretreatment with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA/AM). CONCLUSIONS: Together, in OC2 cells, magnolol induced [Ca2+]i rises by evoking partially PLC-dependent Ca2+ release from the endoplasmic reticulum and Ca2+ entry via PKC-sensitive store-operated Ca2+ entry. Magnolol also caused Ca2+-independent cell death. Therefore, magnolol-induced cytotoxicity may not be involved in activation mechanisms associated with intracellular Ca2+ mobilization in oral cancer cells.


Assuntos
Compostos de Bifenilo/farmacologia , Cálcio/metabolismo , Homeostase/efeitos dos fármacos , Lignanas/farmacologia , Neoplasias Bucais/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Linhagem Celular Tumoral/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citosol/metabolismo , Retículo Endoplasmático/metabolismo , Fura-2/farmacologia , Humanos , Manganês/metabolismo , Proteína Quinase C/efeitos dos fármacos , Proteína Quinase C/metabolismo , Sais de Tetrazólio , Fosfolipases Tipo C/efeitos dos fármacos
5.
Nat Commun ; 6: 6618, 2015 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-25808323

RESUMO

Regulation of GABAergic inhibitory inputs and alterations in POMC neuron activity by nutrients and adiposity signals regulate energy and glucose homeostasis. Thus, understanding how POMC neurons integrate these two signal molecules at the synaptic level is important. Here we show that leptin's action on GABA release to POMC neurons is influenced by glucose levels. Leptin stimulates the JAK2-PI3K pathway in both presynaptic GABAergic terminals and postsynaptic POMC neurons. Inhibition of AMPK activity in presynaptic terminals decreases GABA release at 10 mM glucose. However, postsynaptic TRPC channel opening by the PI3K-PLC signalling pathway in POMC neurons enhances spontaneous GABA release via activation of presynaptic MC3/4 and mGlu receptors at 2.5 mM glucose. High-fat feeding blunts AMPK-dependent presynaptic inhibition, whereas PLC-mediated GABAergic feedback inhibition remains responsive to leptin. Our data indicate that the interplay between glucose and leptin signalling in glutamatergic POMC neurons is critical for determining the strength of inhibitory tone towards POMC neurons.


Assuntos
Glicemia/metabolismo , Neurônios GABAérgicos/efeitos dos fármacos , Leptina/farmacologia , Terminações Pré-Sinápticas/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Proteínas Quinases Ativadas por AMP/efeitos dos fármacos , Animais , Encéfalo/efeitos dos fármacos , Dieta Hiperlipídica , Neurônios GABAérgicos/metabolismo , Glucose , Homeostase , Janus Quinase 2/efeitos dos fármacos , Leptina/metabolismo , Camundongos , Camundongos Transgênicos , Inibição Neural/efeitos dos fármacos , Inibição Neural/genética , Neurônios/metabolismo , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Terminações Pré-Sinápticas/metabolismo , Pró-Opiomelanocortina/metabolismo , Receptor Tipo 3 de Melanocortina/efeitos dos fármacos , Receptor Tipo 4 de Melanocortina/efeitos dos fármacos , Receptores para Leptina/genética , Receptores de Glutamato Metabotrópico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Sinapses/metabolismo , Canais de Cátion TRPC/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos
6.
Mol Endocrinol ; 27(8): 1208-16, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23820900

RESUMO

The release of insulin from pancreatic ß-cells is regulated by a considerable number of G protein-coupled receptors. During the past several years, we have focused on the physiological importance of ß-cell M3 muscarinic acetylcholine receptors (M3Rs). At the molecular level, the M3R selectively activates G proteins of the G(q) family. Phenotypic analysis of several M3R mutant mouse models, including a mouse strain that lacks M3Rs only in pancreatic ß-cells, indicated that ß-cell M3Rs play a key role in maintaining blood glucose levels within a normal range. Additional studies with transgenic M3R mouse models strongly suggest that strategies aimed to enhance signaling through ß-cell M3Rs may prove useful in the treatment of type 2 diabetes. More recently, we analyzed transgenic mice that expressed an M3R-based designer receptor in a ß-cell-specific fashion, which enabled us to chronically activate a ß-cell G(q)-coupled receptor by a drug that is otherwise pharmacologically inert. Drug-dependent activation of this designer receptor stimulated the sequential activation of G(q), phospholipase C, ERK1/2, and insulin receptor substrate 2 signaling, thus triggering a series of events that greatly improved ß-cell function. Most importantly, chronic stimulation of this pathway protected mice against experimentally induced diabetes and glucose intolerance, induced either by streptozotocin or by the consumption of an energy-rich, high-fat diet. Because ß-cells are endowed with numerous receptors that mediate their cellular effects via activation of G(q)-type G proteins, these findings provide a rational basis for the development of novel antidiabetic drugs targeting this class of receptors.


Assuntos
Diabetes Mellitus Tipo 2/prevenção & controle , Intolerância à Glucose/prevenção & controle , Hipoglicemiantes/farmacologia , Células Secretoras de Insulina/metabolismo , Receptor Muscarínico M3/metabolismo , Animais , Glicemia/efeitos dos fármacos , Diabetes Mellitus Tipo 2/tratamento farmacológico , MAP Quinases Reguladas por Sinal Extracelular/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Intolerância à Glucose/tratamento farmacológico , Proteínas Substratos do Receptor de Insulina/efeitos dos fármacos , Proteínas Substratos do Receptor de Insulina/metabolismo , Células Secretoras de Insulina/efeitos dos fármacos , Camundongos , Camundongos Knockout , Receptor Muscarínico M3/efeitos dos fármacos , Receptor Muscarínico M3/genética , Transdução de Sinais , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
7.
Chin J Physiol ; 56(1): 11-7, 2013 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-23347011

RESUMO

In this study, C6 glioma cells were used to test the effects of 2-azafluorenone and its related compounds on membrane phosphatidylinositol (PI) and phosphatidylcholine (PC) turnover. An increase of [³H]-labeled inositol phosphate (IP1) formation by histamine (100 µM) or A23187 (100 nM) via the activation of phosphatidylinositol-specific phospholipase C (PI-PLC) to breakdown labeled substrate was observed, and this effect could be partially blocked by about half at 100 µM of 2-azafluorenones. Histamine induced the increase of IP1 formation, but failed to cause an increase in extracellularly releasing of [3H]choline metabolites, or intracellular accumulation of [³H]phosphscholine. However, platelet activation factor (PAF) from 0.2 to 1 µM, and phorbol 12-myristate-13-acetate (PMA) at 1 µM caused an increase in extracellularly releasing of [³H]choline metabolites, and intracellular accumulation of [³H]phosphocholine via the activation on phosphatidylcholine (PC)-PLC. These responses of PAF and PMA were not affected by 2-azafluorenone or 4-methyl-2-azafluorenone even at high concentration (10⁻4 M). A23187 induced an increase of intracellular [³H]choline release via the activation of PCphospholipase D (PLD). This increasing effect of 100 nM A23187 was not affected by 2-azafluorenone or 4-methyl-2-azafluorenone even at a high concentration of 10⁻4 M. In summary, the inhibitory effect of 2-azafluorenone and its related compound 4-methyl-2-azafluorenone was observed selectively on PIPLC, but not on PC-PLC or PC-PLD based on changes of products after the activation of these enzymes.


Assuntos
Fluorenos/farmacologia , Fosfoinositídeo Fosfolipase C/efeitos dos fármacos , Fosfolipase D/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos , Animais , Calcimicina , Linhagem Celular Tumoral , Ativação Enzimática/efeitos dos fármacos , Histamina , Fosfatidilcolinas/metabolismo , Fosfatidilinositóis/metabolismo , Fosfoinositídeo Fosfolipase C/metabolismo , Fosfolipase D/metabolismo , Fator de Ativação de Plaquetas , Ratos , Acetato de Tetradecanoilforbol , Trítio , Fosfolipases Tipo C/metabolismo
8.
J Recept Signal Transduct Res ; 31(6): 423-33, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22070385

RESUMO

Naturally occurring aroma compounds are able to elicit physiological and migratory responses such as chemotaxis even at nano to femtomolar concentrations in organisms at different levels of phylogeny. Despite the amazing chemical variety of these substances the apparatus by which they can be detected i.e. the chemosensory receptors and the signaling pathways seem to be rather uniform and evolutionary well-conserved. The intracellular signaling process is supposed to be mediated by either cAMP or inositol 1,4,5-trisphosphate. The present work aimed to investigate the chemotactic behavior of 11 odorants that occur naturally in foods and are also used by the industry as additives, on the eukaryotic ciliate Tetrahymena pyriformis. Intracellular signaling pathways that might be activated by these compounds were also investigated. Activation of the phospholipase C (PLC) was measured by FACS and the stimulation of inositol-1,4,5-trisphosphate 3-kinases (IP3K) was measured using two specific inhibitors, wortmannin and LY294002. The strongest chemoattractant character was observed for isoamyl acetate (10(⁻6) M), propyl isobutyrate (10(⁻8) M), isobutyl propionate (10(⁻6) M). The strongest repellent action was exerted by benzyl acetate (10(⁻8) M), furfuryl thioacetate (10(⁻12) M). Our results suggest that Tetrahymena responds in a very sensitive way to slight changes in the molecular structure. According to our study, tracer amounts of solvents do not contribute significantly to the chemotactic profile of the respective odorants. No significant activation of PLC or PI3K could be observed following stimulation with attractant odorants which implies that some other pathways may be involved, hence further investigation is needed.


Assuntos
Fatores Quimiotáticos/química , Quimiotaxia/fisiologia , AMP Cíclico/metabolismo , Inositol 1,4,5-Trifosfato/metabolismo , Tetrahymena pyriformis/fisiologia , Fosfolipases Tipo C/metabolismo , Fatores Quimiotáticos/farmacologia , Fatores Quimiotáticos/fisiologia , Aditivos Alimentares/química , Aditivos Alimentares/farmacologia , Regulação da Expressão Gênica , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Receptores Odorantes/metabolismo , Transdução de Sinais/efeitos dos fármacos , Tetrahymena pyriformis/efeitos dos fármacos , Tetrahymena pyriformis/metabolismo , Fosfolipases Tipo C/antagonistas & inibidores , Fosfolipases Tipo C/efeitos dos fármacos
9.
PLoS Pathog ; 6(4): e1000834, 2010 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-20368969

RESUMO

Acinetobacter baumannii is a common pathogen whose recent resistance to drugs has emerged as a major health problem. Ethanol has been found to increase the virulence of A. baumannii in Dictyostelium discoideum and Caenorhabditis elegans models of infection. To better understand the causes of this effect, we examined the transcriptional profile of A. baumannii grown in the presence or absence of ethanol using RNA-Seq. Using the Illumina/Solexa platform, a total of 43,453,960 reads (35 nt) were obtained, of which 3,596,474 mapped uniquely to the genome. Our analysis revealed that ethanol induces the expression of 49 genes that belong to different functional categories. A strong induction was observed for genes encoding metabolic enzymes, indicating that ethanol is efficiently assimilated. In addition, we detected the induction of genes encoding stress proteins, including upsA, hsp90, groEL and lon as well as permeases, efflux pumps and a secreted phospholipase C. In stationary phase, ethanol strongly induced several genes involved with iron assimilation and a high-affinity phosphate transport system, indicating that A. baumannii makes a better use of the iron and phosphate resources in the medium when ethanol is used as a carbon source. To evaluate the role of phospholipase C (Plc1) in virulence, we generated and analyzed a deletion mutant for plc1. This strain exhibits a modest, but reproducible, reduction in the cytotoxic effect caused by A. baumannii on epithelial cells, suggesting that phospholipase C is important for virulence. Overall, our results indicate the power of applying RNA-Seq to identify key modulators of bacterial pathogenesis. We suggest that the effect of ethanol on the virulence of A. baumannii is multifactorial and includes a general stress response and other specific components such as phospholipase C.


Assuntos
Acinetobacter baumannii/efeitos dos fármacos , Acinetobacter baumannii/patogenicidade , Depressores do Sistema Nervoso Central/farmacologia , Etanol/farmacologia , Expressão Gênica/efeitos dos fármacos , RNA Bacteriano/análise , Infecções por Acinetobacter/metabolismo , Infecções por Acinetobacter/patologia , Acinetobacter baumannii/genética , Linhagem Celular , Perfilação da Expressão Gênica , Regulação Bacteriana da Expressão Gênica/efeitos dos fármacos , Regulação Bacteriana da Expressão Gênica/genética , Humanos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fosfolipases Tipo C/biossíntese , Fosfolipases Tipo C/efeitos dos fármacos , Virulência/efeitos dos fármacos , Virulência/genética
10.
Chin J Physiol ; 53(5): 271-84, 2010 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-21793338

RESUMO

The role of ionic currents on procaine-elicited action potential bursts was studied in an identifiable RP1 neuron of the African snail, Achatina fulica Ferussac, using the two-electrode voltage clamp method. The RP1 neuron generated spontaneous action potentials and bath application of procaine at 10 mM reversibly elicited action potential bursts in a concentration-dependent manner. Voltage clamp studies revealed that procaine at 10 mM decreased [1] the Ca2+ current, [2] the Na+ current, [3] the delayed rectifying K+ current I(KD), and [4] the fast-inactivating K+ current (I(A)). Action potential bursts were not elicited by 4-aminopyridine (4-AP), an inhibitor of I(A), whereas they were seen after application of tetraethylammonium chloride (TEA), a blocker of the I(K)(Ca) and I(KD) currents, and tacrine, an inhibitor of I(KD). Pretreatment with U73122, a phospholipase C inhibitor, blocked the action potential bursts elicited by procaine. U73122 did not affect the I(KD) of the RP1 neuron; however, U73122 decreased the inhibitory effect of procaine on the I(KD). Tacrine decreased the TEA-sensitive I(KD) of RP1 neuron but did not significantly affect the I(A). Tacrine also successfully induced action potential bursts in the RP1 neuron. It is concluded that the inhibition on the I(KD) is responsible for the generation of action potential bursts in the central snail RP1 neuron. Further, phospholipase C activity is involved in the procaine-elicited I(KD) inhibition and action potential bursts.


Assuntos
Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Canais Iônicos/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Procaína/farmacologia , Caramujos/fisiologia , 4-Aminopiridina/farmacologia , Anestésicos Locais/farmacologia , Animais , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/fisiologia , Relação Dose-Resposta a Droga , Estrenos/farmacologia , Canais Iônicos/efeitos dos fármacos , Modelos Animais , Técnicas de Patch-Clamp , Canais de Potássio/efeitos dos fármacos , Canais de Potássio/fisiologia , Pirrolidinonas/farmacologia , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/fisiologia , Tacrina/farmacologia , Tetraetilamônio/farmacologia , Fosfolipases Tipo C/antagonistas & inibidores , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/fisiologia
11.
Auton Neurosci ; 151(2): 174-7, 2009 Dec 03.
Artigo em Inglês | MEDLINE | ID: mdl-19559657

RESUMO

Adenosine acts in the nucleus tractus solitarii (NTS), one of the main brain sites related to cardiovascular control. In the present study we show that A(1) adenosine receptor (A(1R)) activation promotes an increase on alpha(2)-adrenoceptor (Alpha(2R)) binding in brainstem cell culture from newborn rats. We investigated the intracellular cascade involved in such modulatory process using different intracellular signaling molecule inhibitors as well as calcium chelators. Phospholipase C, protein kinase Ca(2+)-dependent, IP(3) receptor and intracellular calcium were shown to participate in A(1R)/Alpha(2R) interaction. In conclusion, this result might be important to understand the role of adenosine within the NTS regarding autonomic cardiovascular control.


Assuntos
Adenosina/metabolismo , Tronco Encefálico/metabolismo , Receptores Adrenérgicos alfa 2/metabolismo , Transdução de Sinais/fisiologia , Núcleo Solitário/metabolismo , Fosfolipases Tipo C/metabolismo , Adenosina/farmacologia , Animais , Vias Autônomas/efeitos dos fármacos , Vias Autônomas/metabolismo , Tronco Encefálico/efeitos dos fármacos , Cálcio/metabolismo , Sinalização do Cálcio/efeitos dos fármacos , Sinalização do Cálcio/fisiologia , Fenômenos Fisiológicos Cardiovasculares/efeitos dos fármacos , Células Cultivadas , Quelantes/farmacologia , Coração/inervação , Coração/fisiologia , Receptores de Inositol 1,4,5-Trifosfato/efeitos dos fármacos , Receptores de Inositol 1,4,5-Trifosfato/metabolismo , Ratos , Ratos Wistar , Receptores Adrenérgicos alfa 2/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Núcleo Solitário/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos
12.
Neurochem Int ; 54(5-6): 385-92, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19418634

RESUMO

Activity-dependent transcriptional up-regulation of bdnf (brain-derived neurotrophic factor) is involved in regulating many aspects of neuronal functions. The NMDA (N-methyl-D-aspartic acid)-mediated and BDNF-mediated exon IV transcription may represent mechanistically different responses, and relevant to activity-dependent changes in neurons. We found that the activities of ERK (extracellular signal regulated kinase), CaM KII/IV (calmodulin-dependent protein kinase II and IV), PI3K (phosphoinositide 3-kinase), and PLC (phospholipase C) are required for NMDA receptor-mediated bdnf exon IV transcription in cultured cortical neurons. In contrast, the BDNF-induced and TrkB-dependent exon IV transcription was regulated by ERK and CaM KII/IV, but not by PI3K and PLC. While ERK and CaM KII/IV are separate signaling pathways in BDNF-stimulated neurons, CaM KII/IV appeared to regulate exon IV transcription through ERK in NMDA-stimulated neurons. Similarly, the PI3K and PLC signaling pathways converged on ERK in NMDA- but not BDNF-stimulated neurons. Our results implicate that the NMDA-induced and the self-maintenance of bdnf transcription are differentially regulated.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/genética , Córtex Cerebral/metabolismo , Neurônios/metabolismo , Animais , Animais Recém-Nascidos , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/efeitos dos fármacos , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/metabolismo , Células Cultivadas , Córtex Cerebral/efeitos dos fármacos , Agonistas de Aminoácidos Excitatórios/farmacologia , Éxons/efeitos dos fármacos , Éxons/genética , MAP Quinases Reguladas por Sinal Extracelular/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Regulação da Expressão Gênica/genética , N-Metilaspartato/farmacologia , Neurônios/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Ratos , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Transcrição Gênica/efeitos dos fármacos , Transcrição Gênica/genética , Ativação Transcricional/efeitos dos fármacos , Ativação Transcricional/genética , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/genética
13.
Proc Natl Acad Sci U S A ; 106(13): 5400-5, 2009 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-19289841

RESUMO

Canonical transient receptor potential (TRPC) channels control influxes of Ca(2+) and other cations that induce diverse cellular processes upon stimulation of plasma membrane receptors coupled to phospholipase C (PLC). Invention of subtype-specific inhibitors for TRPCs is crucial for distinction of respective TRPC channels that play particular physiological roles in native systems. Here, we identify a pyrazole compound (Pyr3), which selectively inhibits TRPC3 channels. Structure-function relationship studies of pyrazole compounds showed that the trichloroacrylic amide group is important for the TRPC3 selectivity of Pyr3. Electrophysiological and photoaffinity labeling experiments reveal a direct action of Pyr3 on the TRPC3 protein. In DT40 B lymphocytes, Pyr3 potently eliminated the Ca(2+) influx-dependent PLC translocation to the plasma membrane and late oscillatory phase of B cell receptor-induced Ca(2+) response. Moreover, Pyr3 attenuated activation of nuclear factor of activated T cells, a Ca(2+)-dependent transcription factor, and hypertrophic growth in rat neonatal cardiomyocytes, and in vivo pressure overload-induced cardiac hypertrophy in mice. These findings on important roles of native TRPC3 channels are strikingly consistent with previous genetic studies. Thus, the TRPC3-selective inhibitor Pyr3 is a powerful tool to study in vivo function of TRPC3, suggesting a pharmaceutical potential of Pyr3 in treatments of TRPC3-related diseases such as cardiac hypertrophy.


Assuntos
Pirazóis/farmacologia , Canais de Cátion TRPC/antagonistas & inibidores , Amidas , Animais , Linfócitos B , Cálcio/metabolismo , Linhagem Celular , Hipertrofia/tratamento farmacológico , Camundongos , Miócitos Cardíacos/patologia , Fatores de Transcrição NFATC/efeitos dos fármacos , Fatores de Transcrição NFATC/metabolismo , Transporte Proteico/efeitos dos fármacos , Pirazóis/química , Ratos , Relação Estrutura-Atividade , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
14.
Pharmacology ; 83(3): 131-40, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19092285

RESUMO

At the sites of inflammation, leukocytes are confronted with mediators which induce different cellular responses like chemotaxis, degranulation and respiratory burst. Morphologically, these responses are accompanied by changes in the cells' shape. In this study, we investigated the involvement of the actin cytoskeleton and Ca2+ in the shape change responses of human eosinophils and neutrophils to chemoattractants and correlated the obtained findings to degranulation and respiratory burst using flow cytometry. Shape change was recorded as an increase in forward scatter. Degranulation was measured as the cell surface upregulation of the granule-associated marker CD63. Respiratory burst was determined fluorimetrically as the oxidation of dihydrorhodamine 123. The involvement of actin filaments and phospholipase C (PLC) was investigated with the actin inhibitor cytochalasin B and the selective PLC inhibitor U-73122, respectively. The data that we obtained demonstrated that granulocytes exhibit 2 distinct types of shape change responses when stimulated with chemoattractants: (i) one type is induced by chemokines like eotaxin and interleukin 8, which are poor degranulators, and also by classical chemoattractants, C5a and formyl-methionyl-leucyl-phenylalanine; this shape change depends on the activation of PLC and functional actin filaments, but does not require Ca2+ influx from outside; (ii) the second type of shape change is not stimulated by chemokines, but can be seen with classical chemoattractants which are also potent inducers of degranulation and respiratory burst. This type of shape change does not require any functional actin filaments, but appears to be a consequence of degranulation and depends essentially on the activation of PLC and Ca2+ influx from the extracellular space.


Assuntos
Citoesqueleto de Actina/fisiologia , Cálcio/fisiologia , Eosinófilos/citologia , Eosinófilos/fisiologia , Neutrófilos/citologia , Neutrófilos/fisiologia , Citoesqueleto de Actina/efeitos dos fármacos , Antígenos CD , Cálcio/metabolismo , Cálcio/farmacologia , Moléculas de Adesão Celular/metabolismo , Degranulação Celular/efeitos dos fármacos , Forma Celular/efeitos dos fármacos , Quimiocinas/farmacologia , Fatores Quimiotáticos/farmacologia , Citocalasina B/farmacologia , Eosinófilos/efeitos dos fármacos , Estrenos/farmacologia , Humanos , Leucócitos/citologia , Leucócitos/efeitos dos fármacos , Leucócitos/fisiologia , Neutrófilos/efeitos dos fármacos , Inibidores de Fosfodiesterase/farmacologia , Glicoproteínas da Membrana de Plaquetas , Pirrolidinonas/farmacologia , Explosão Respiratória , Tetraspanina 30 , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
15.
J Pharmacol Sci ; 107(4): 443-50, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18678987

RESUMO

Extracellular nucleotides are primary signals for tissue injury, acting together with various chemical mediators such as prostanoids at the inflammatory site. We investigated whether prostaglandin E2 (PGE2) affects purinergic signaling in murine J774 macrophages. J774 cells expressed four different purinoceptor mRNAs: the ionotropic P2X4 and P2X7 receptors and G-protein-coupled P2Y2 and P2Y6 receptors. Functional responses mediated by these purinoceptor subtypes were confirmed by measurement of intracellular Ca2+ concentration ([Ca2+]i) in fura-2-loaded cells. Thus, low concentrations (10 microM) of ATP (P2Y2 agonist) and UDP (P2Y6 agonist) evoked Ca2+ transient in a phospholipase C (PLC)-dependent manner, whereas the P2X7 agonist benzoylbenzoyl-ATP (BzATP, 500 microM) caused a sustained rise in [Ca2+]i. Furthermore, ivermectin, an activator of the P2X4-receptor channel, enhanced the ATP-induced [Ca2+]i elevation. PGE2 inhibited ATP- and UDP-induced [Ca2+]i elevation, without affecting the BzATP-induced sustained [Ca2+]i elevation. Stimulation of J774 cells by UDP or BzATP increased the production of macrophage inflammatory peptide-alpha (MIP-alpha). PGE2 abolished the UDP-induced MIP-alpha production, but not the BzATP-induced one. These results demonstrate that purinergic signalings in macrophages were regulated by PGE2 in a subtype-specific manner. The different inhibitory effects on distinct purinoceptor functions may be related to the anti-inflammatory property of PGE2.


Assuntos
Cálcio/metabolismo , Dinoprostona/farmacologia , Receptores Purinérgicos P2/efeitos dos fármacos , Trifosfato de Adenosina/farmacologia , Animais , Linhagem Celular , Quimiocina CCL3/efeitos dos fármacos , Quimiocina CCL3/metabolismo , Dinoprostona/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , RNA Mensageiro/metabolismo , Receptores Purinérgicos P2/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
16.
J Neurosci Res ; 86(15): 3295-305, 2008 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-18615645

RESUMO

Pregnant Wistar rats were orally treated with the adenosine receptor agonist R-phenylisopropyladenosine (R-PIA) throughout the gestational period, and the status of the metabotropic glutamate (mGlu) receptor/phospholipase C transduction pathway from maternal and fetal brain was analyzed. In mothers' brains, radioligand binding assays revealed a significant decrease in the Bmax value, without any significant alteration in Kd value. Similar results were observed in the steady-state level of mGlu(1) and mGlu(5) receptors assayed by Western blot, suggesting that both receptor subtypes were modulated by chronic R-PIA treatment. mRNA coding mGlu(1) or mGlu(5) receptors was not altered, suggesting a posttranscriptional modulation as a possible mechanism of the loss of mGlu(1) and mGlu(5) receptors at the membrane surface. Moreover, phospholipase C stimulated by (R,S)-3,5-dihydroxyphenylglycine (DHPG), a selective agonist of group I mGlu receptors, was also significantly decreased after R-PIA treatment, suggesting a heterologous desensitization of group I mGlu/PLC pathway in maternal brain. Western blot and RT-PCR assays showed that neither alphaG(q/11) nor PLCbeta(1) was affected by R-PIA treatment. In fetal brain, no significant differences in mGlu receptors/PLC transduction pathway were observed after R-PIA treatment. These results suggest that chronic R-PIA intake during pregnancy modulates group I mGlu receptor signalling pathway in maternal brain, promoting a down-regulation of mGlu(1) and mGlu(5) receptors and a heterologous desensitization of the mGlu/PLC system.


Assuntos
Adenosina/análogos & derivados , Exposição Materna , Fármacos Neuroprotetores/farmacologia , Efeitos Tardios da Exposição Pré-Natal , Receptores de Glutamato Metabotrópico/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos , Adenosina/farmacologia , Agonistas do Receptor A1 de Adenosina , Adenilil Ciclases/efeitos dos fármacos , Adenilil Ciclases/metabolismo , Animais , Western Blotting , Encéfalo/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Feminino , Feto , Gravidez , RNA Mensageiro/análise , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais/efeitos dos fármacos
17.
Naunyn Schmiedebergs Arch Pharmacol ; 378(5): 503-14, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18551279

RESUMO

Luteinizing hormone (LH) and human chorionic gonadotropin (hCG) activate the LH receptor/cyclic AMP (cAMP) signaling pathway to induce ovulation. As an alternative to parenterally administered hCG to treat anovulatory infertility, orally active low molecular weight (LMW) LHR agonists have been developed at Organon. In this paper, we present the mechanism of action of a prototypic, nanomolar potent and almost full LHR agonist, Org 43553. Org 43553 interacts with the endodomain of the LHR, whereas LH acts via the N-terminal exodomain. LH stimulates the cAMP pathway with an EC50 of 35 pM, but this stimulation is not antagonized by simultaneous incubation with Org 43553. At nanomolar concentrations, LH also stimulates phospholipase C (PLC), but Org 43553 is hardly able to do so. In contrast, Org 43553 inhibits LH-induced PLC (IC50 approximately 10 nM). While Org 43553 stimulates dissociation of [125I]hCG from the LHR and reduces [125I]hCG binding, LH reduces specific [3H]Org 43553 binding. We conclude that Org 43553 is a signaling-selective, allosteric LHR agonist. We hypothesize that Org 43553 and LH induce a similar LHR conformation necessary for activating adenylyl cyclase, which initiates most, if not all, physiological responses of LH.


Assuntos
Adenilil Ciclases/metabolismo , AMP Cíclico/metabolismo , Pirimidinas/farmacologia , Receptores do LH/agonistas , Tiofenos/farmacologia , Regulação Alostérica , Animais , Células CHO , Linhagem Celular , Gonadotropina Coriônica/metabolismo , Cricetinae , Cricetulus , Humanos , Concentração Inibidora 50 , Hormônio Luteinizante/administração & dosagem , Hormônio Luteinizante/farmacologia , Pirimidinas/administração & dosagem , Transdução de Sinais/efeitos dos fármacos , Tiofenos/administração & dosagem , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
18.
J Pharm Pharmacol ; 59(9): 1255-61, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17883897

RESUMO

Gabapentin (Neurontin) is an analogue of gamma-aminobutyric acid (GABA) that is effective against partial seizures. Gabapentin has been reported to modulate serotonin release from platelets, but the effects of gabapentin on platelet activation have not been explored. In this study, gabapentin concentration-dependently (60-240 microM) inhibited platelet aggregation in washed platelets stimulated by collagen (1 microg mL(-1)), ADP (20 microM) and arachidonic acid (60 microM). Gabapentin (120 and 240 microM) also concentration-dependently inhibited collagen (1 microg mL(-1))-induced phosphoinositide breakdown, intracellular Ca(2+) mobilization, thromboxane A(2) formation, and p38 MAPK phosphorylation in human platelets. In conclusion, the most important findings of this study suggest that gabapentin inhibits platelet aggregation, at least in part, through the phospholipase C-inositol 1,4,5-trisphosphate-thromboxane A(2)-Ca(2+) pathway. Thus, it is possible that gabapentin treatment, alone or in combination with other antiplatelet drugs, may induce or potentiate inhibition of platelet aggregation, which may affect haemostasis in-vivo.


Assuntos
Aminas/farmacologia , Anticonvulsivantes/farmacologia , Ácidos Cicloexanocarboxílicos/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Aminas/administração & dosagem , Anticonvulsivantes/administração & dosagem , Cálcio/metabolismo , Ácidos Cicloexanocarboxílicos/administração & dosagem , Relação Dose-Resposta a Droga , Citometria de Fluxo , Gabapentina , Humanos , Immunoblotting , Técnicas In Vitro , Inositol 1,4,5-Trifosfato/metabolismo , Fosfatidilinositóis/metabolismo , Fosforilação/efeitos dos fármacos , Tromboxano A2/biossíntese , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo , Ácido gama-Aminobutírico/administração & dosagem , Proteínas Quinases p38 Ativadas por Mitógeno/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
19.
Neuroimmunomodulation ; 14(6): 344-53, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18463421

RESUMO

OBJECTIVES: Previous work in our laboratory has shown that alpha-adrenoreceptors (alpha-ARs) and beta-ARs exist on lymphocytes from functional profile, and that the receptors mediate the regulation of lymphocyte function by catecholamines. In the present study, we directly examined the expression of alpha-AR subtypes, alpha(1)-AR and alpha(2)-AR mRNAs, in T lymphocytes and explored the roles of the alpha-AR subtypes and intracellular signal transduction mechanisms linked to the receptors in mediating the modulation of T lymphocyte function. METHODS: T lymphocytes from mesenteric lymph nodes of rats were purified by using a nylon wool column. Reverse transcription polymerase chain reaction was used to detect the expression of alpha(1)-AR and alpha(2)-AR mRNAs in the freshly isolated T cells and the mitogen concanavalin A (Con A)-activated lymphocytes. Colorimetric methylthiazoletetrazolium assay was employed to measure lymphocyte proliferation induced by Con A. Interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) levels in the Con A-stimulated lymphocyte culture supernatants were examined by enzyme-linked immunosorbent assay. RESULTS: T cells expressed both alpha(1)-AR and alpha(2)-AR mRNAs. The expression of both alpha(1)-AR and alpha(2)-AR mRNAs was significantly higher in the Con A-activated lymphocytes than in the resting lymphocytes. Phenylephrine, a selective alpha(1)-AR agonist, had no evident effect on lymphocyte proliferation nor on IFN-gamma and IL-4 production induced by Con A. However, the selective alpha(2)-AR agonist clonidine attenuated Con A-induced lymphocyte proliferation as well as IFN-gamma and IL-4 production. The inhibited lymphocyte proliferation and IFN-gamma and IL-4 production by clonidine were blocked by yohimbine, an alpha(2)-AR antagonist. Either phospholipase C inhibitor U-73122 or protein kinase C inhibitor chelerythrine partially prevented the suppressive effect of clonidine on Con A-stimulated lymphocyte proliferation and IL-4 production. CONCLUSIONS: T lymphocytes express both alpha(1)-ARs and alpha(2)-ARs, but only the alpha(2)-ARs participate in the suppressive modulation of lymphocyte proliferation and cytokine production in vitro. The inhibitory effect of alpha(2)-AR stimulation on lymphocyte function is partially mediated via the phospholipase C-protein kinase C pathway.


Assuntos
Receptores Adrenérgicos alfa/metabolismo , Transdução de Sinais/imunologia , Linfócitos T/imunologia , Agonistas alfa-Adrenérgicos/farmacologia , Antagonistas Adrenérgicos alfa/farmacologia , Animais , Proliferação de Células , Inibidores Enzimáticos/farmacologia , Ensaio de Imunoadsorção Enzimática , Interferon gama/biossíntese , Interleucina-4/biossíntese , Ativação Linfocitária/imunologia , Isoformas de Proteínas/metabolismo , Proteína Quinase C/efeitos dos fármacos , Proteína Quinase C/metabolismo , RNA Mensageiro/análise , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos alfa/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Linfócitos T/metabolismo , Fosfolipases Tipo C/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
20.
J Parasitol ; 93(5): 1202-7, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18163358

RESUMO

Alkyl-lysophospholipids (ALPs), developed initially to be antitumor agents, have proved highly effective in the treatment of visceral leishmaniasis, a disease caused by the species making up the protozoan complex Leishmania donovani. Although their effectiveness is known, the mode of action against this parasite is not completely understood. In the present work, we have studied the effect of 3 derivatives, edelfosine, miltefosine, and ilmofosine. Using nuclear magnetic resonance spectroscopy ('H-NMR), we have examined the excreted catabolites from glucose metabolism in the promastigote forms treated with these compounds. The ALPs at concentrations of 19 and 38 microM inhibit the excretion of acetate, succinate, and pyruvate. The effect of edelfosine, miltefosine, and ilmofosine on the activity of the enzymes hexokinase, glycerolkinase 3-PD, phosphoglucose isomerase, superoxide dismutase, and phospholipase C were also examined. Glycerolkinase 3-PD and phosphoglucose isomerase are generally insensitive to the compounds, whereas hexokinase and superoxide dismutase are inhibited by miltefosine and ilmofosine. The ALPs exhibited an activated effect against the phospholipase C activity. Alkyl-lysophospholipids were shown to have a significant effect on several enzymes in important biochemical pathways indispensable for the survival of L. donovani promasigotes.


Assuntos
Leishmania donovani/efeitos dos fármacos , Leishmania donovani/enzimologia , Éteres Fosfolipídicos/farmacologia , Proteínas de Protozoários/efeitos dos fármacos , Animais , Metabolismo dos Carboidratos/efeitos dos fármacos , Humanos , Leishmania donovani/crescimento & desenvolvimento , Leishmania donovani/ultraestrutura , Espectroscopia de Ressonância Magnética , Testes de Sensibilidade Parasitária , Éteres Fosfolipídicos/química , Fosforilcolina/análogos & derivados , Fosforilcolina/química , Fosforilcolina/farmacologia , Proteínas de Protozoários/metabolismo , Superóxido Dismutase/efeitos dos fármacos , Fosfolipases Tipo C/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA